Earnings Outlook For Xenon Pharmaceuticals
Portfolio Pulse from Benzinga Insights
Xenon Pharmaceuticals (NASDAQ:XENE) is set to release its latest quarterly earnings report on November 8, 2023. Analysts estimate an earnings per share (EPS) of $-0.77. The company's past performance shows a pattern of share price changes following earnings reports. The stock was trading at $32.86 as of November 3, with a 0.6% decrease over the last 52-week period.
November 07, 2023 | 2:01 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Xenon Pharmaceuticals is expected to report an EPS of $-0.77. Past earnings reports have influenced the company's share price. The stock is currently down 0.6% over the last 52 weeks.
The upcoming earnings report is highly relevant to Xenon Pharmaceuticals' stock. Past earnings reports have shown a pattern of influencing the share price. However, the stock has been generally decreasing over the past year, which may indicate investor sentiment towards the company. The score is neutral as the direction of the impact will depend on the actual earnings reported and the company's guidance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100